The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

NCT02114645 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Infertility

Interventions

DRUG: Leuprolide acetate
DRUG: vaginal progesterone
DRUG: 4 mg oral estradiol valerate

Sponsor

Zekai Tahir Burak Women's Health Research and Education Hospital